ComPAS Low-WAZ RCT Mali

Status Active, not recruiting

Clinical Trial Summary

Admissions criteria which treat children with only low mid-upper arm circumference (MUAC) or children with low weight-for-height z-score (WHZ) are not aligned with the evidence on which children are at risk of mortality. An analysis of community-based cohort data from Senegal found that a combination of weight-for-age z-score (WAZ) and MUAC criteria identified all children at risk of near-term death associated with severe anthropometric deficits. This finding has led to the suggestion that WAZ<-3 could be added as an independent admissions criterion for therapeutic feeding programs currently admitting children with MUAC<125 mm. However, there is little evidence to inform the debate about whether children with MUAC ≥125 mm and WAZ<-3 would benefit from treatment and, if so, what treatment protocol should be used. This study will address whether children with WAZ <-3 but MUAC ≥125 mm benefit from therapeutic feeding and whether a simplified protocol is at least as effective as the more complicated weight-based standard protocol for this population. The study will be a prospective, multi-center, individually randomized controlled trial (RCT). Children aged 6-59 months presenting with MUAC ≥125 mm and WAZ<-3 will be randomized to one of three study arms. The primary objective of this study is to assess whether therapeutic feeding with a simplified protocol (1 sachet RUTF/day) results in superior nutritional outcomes compared to no therapeutic feeding AND non-inferior nutritional outcomes compared to the WHZ and weight based dosing regimen currently used in CMAM treatment 2 months after diagnosis among children aged 6-59 months with MUAC ≥125 mm and WAZ<-3 . The primary outcome is the mean WAZ of children. Secondary outcomes include a) proportion of children with WAZ <-3, b) mean MUAC of children, c) proportion of children with MUAC < 125 mm, d) mean WHZ, mean HAZ, e) proportion of children with WHZ<-3 or HAZ<-3, f) change in WAZ, MUAC, WHZ, HAZ from enrolment to endpoint g) mean skinfold thickness measure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05248516
Study type	Interventional
Source	International Rescue Committee
Contact
Status	Active, not recruiting
Phase	Phase 2/Phase 3
Start date	September 1, 2022
Completion date	April 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02451410` - An Intervention to Improve Nutrition and Physical Activity in Preschoolers in Cuenca, Ecuador	N/A
Completed	`NCT05517395` - The Effectiveness of HBM-based Education Program on Improve Knowledge and Behaviors	N/A
Completed	`NCT04561635` - Effects of Multiple-micronutrients Supplementation on Growth and Iron Status of Indigenous Children in Malaysia	N/A
Recruiting	`NCT03398343` - Nutritional Therapy on Underweight Critically Ill Patients: an Observational Study	N/A
Completed	`NCT01553552` - Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal	N/A
Completed	`NCT05574842` - The Effect of Double Duty Interventions on Double Burden of Malnutrition Among School Adolescents in Ethiopia	N/A
Completed	`NCT05077059` - Prevalence of Obesity and Overweight in Primary School Children in the Rhein-Neckar Region in Germany
Completed	`NCT03847662` - Scaling up Small-Scale Food Processing to Promote Food Security Among Women Farmers in Rural Vietnam
Completed	`NCT03378141` - Maternal Nutrition Interventions in Uttar Pradesh, India	N/A
Completed	`NCT05346549` - Energy Regulation and Nutritional Status of Children: A Satiation Study	N/A
Recruiting	`NCT05793294` - Child Health, Nutrition and Microbiome Development
Completed	`NCT04851327` - Satiation Study With Children Attending a Tertiary Feeding Clinic	N/A
Completed	`NCT04848129` - Genetic Correlates of Wasting: a Pilot Study With Children Attending a Tertiary Feeding Clinic
Completed	`NCT03523182` - Spirulina Supplementation and Infant Growth, Morbidity and Motor Development	N/A
Recruiting	`NCT05881447` - Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Completed	`NCT04631978` - Analysis of Retinochoroidal Vasculature in Underweight Women Using Optical Coherence Tomography Angiography
Active, not recruiting	`NCT05952076` - Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants	Phase 3
Not yet recruiting	`NCT06309576` - Experimental Approach to Test Predictions of Body Weight Regulation Models	N/A
Not yet recruiting	`NCT05457712` - Nutrition In Preoperative Pediatric Congenital Heart Disease	N/A
Active, not recruiting	`NCT03638557` - School Lunch Program (SLP) Towards Nutrition Knowledge, Attitude, Practices and Nutrition Status of Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.